Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Saloner presentation
1. MR Imaging for the Evaluation of
Carotid Atherosclerosis
David Saloner, PhD
Professor of Radiology
VA Medical Center
University of California San Francisco
2. What is the risk factor associated
with carotid disease?
a b c d
Identical diameter stenosis but different geometries
and/or composition
4. High Resolution MRI of Resected Plaque
• Provides perspective on wealth of
information available from MR imaging of
geometry and composition
• (200µm)3
resolution (not currently obtainable
in vivo)
7. Fibrous cap over necrotic core
Histology MRI
MRI shows good contrast between fibrous cap and
necrotic core as confirmed on histology
8. High Resolution MRI In Vivo
• Can we obtain comparable data in vivo that will
provide measures of 3d descriptors?
Will these permit us to follow the progression of
geometry (X-sectional area, plaque bulk), and
compositional features (lipidic core, fibrous cap)?
• Can we identify the features of the plaque that
correlate with rapid progression in a prospective
fashion?
• Can we identify the features of the plaque that confer
neurological risk?
16. High resoln. MRA of lumenal contours in vivo
• Provides good delineation of vascular contours
with reasonable resolution - about 0.5 mm3
voxel
• 3D depiction of contours
• Little or no invasiveness
• Provides potential to evaluate cross-sectional area,
and surface irregularities
19. High resoln. MRI of vessel wall in vivo
• Provides good delineation of plaque components
with reasonable resolution - about 0.5 mm3
voxel
• Sequential 2D slices providing 3D overview
• Non invasive
• Provides potential to evaluate plaque
inhomogeneity - perhaps lipid core, fibrous cap,
calcification, intraplaque hemorrhage
20. Dr. David Saloner, VASF, and Dr. F. Scott Pereles, Northwestern
High Resolution
Carotid Imaging
3D CE-MRA 3D TrueFISP 2D T2-TSE
New rapid methods - new hardware
21. Future of MRA/I
• Improved hardware and software
• Use of 3D black blood studies, plaque enhancement
following contrast injection
• Implementation in longitudinal studies of disease
progression/regression
• Establish true determinants of neurological risk